Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.

Por Christoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, Claudia Hube-Magg, Martina Kluth, Nathaniel Melling, Patrick Lebok, Sarah Minner, Christina Koop, Markus Graefen, Hans Heinzer, Corinna Wittmer, Guido Sauter, Waldemar Wilczak, Ronald Simon, Thorsten Schlomm, Stefan Steurer, Till Krech
Publicado em 2015-01-01